Therefore, the effect of statins on targeted drug resistance to lung cancer remains to be investigated.<h4>Methods</h4>Prolonged exposure to gefitinib resulted in the emergence of a resistant lung cancer cell line (PC9GR) from the parental sensitive cell line (PC9), which exhibited a traditional EGFR mutation. This evidence concerns the gene EGFR and lung carcinoma.